MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Minoryx.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Minoryx.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Minoryx.com most likely does not offer any adult content.
Popular pages
-
Minoryx Leriglitazone
Leriglitazone is currently being evaluated in a pivotal phase 2/3 clinical trial (ADVANCE) in adult AMN patients and a phase 2 trial (FRAMES) in patients with FRDA
-
Minoryx is a clinical stage biotech company
Minoryx is a clinical stage biotech company focused on the discovery and development of novel therapies for severe, orphan genetic diseases of the central nervous system.
-
Minoryx funding
Deprecated: strpos(): Passing null to parameter #1 ($haystack) of type string is deprecated in /var/www/vhosts/minoryx.com/httpdocs/app/lib/eM/Gestor_Public.php on line 206 /var/www/vhosts/minoryx....
-
Minoryx Careers
Working at Minoryx We are driven and committed to making new treatments available for patients suffering from severe, orphan CNS diseases. Our culture is defined for being perseverant and passionate f...
-
Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2
Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2 study in Friedreich´s ataxia Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proo...
-
Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102
Minoryx Therapeutics Initiates Phase 1 clinical trial of MIN-102 2016-07-06 MIN-102, a differentiated PPAR agonist, targets X-linked Adrenoleukodystrophy (X-ALD), a life threatening orphan CNS diseas...